Exploring the frontier: promising survival in selected patients after CRS and HIPEC for peritoneal metastases from hepatocellular carcinoma—a systematic review

Puntos clave

• Survival is notably improved in selected patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
• Key evidence shows improved survival rates in patients with peritoneal metastases from hepatocellular carcinoma.
• Systematic review of CRS and HIPEC interventions identified significant outcomes across various studies.
• Findings may improve clinical decision-making for treating hepatocellular carcinoma with peritoneal metastases.